Cancer IQ Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Cancer IQ's estimated annual revenue is currently $6.8M per year.(i)
  • Cancer IQ's estimated revenue per employee is $126,000

Employee Data

  • Cancer IQ has 54 Employees.(i)
  • Cancer IQ grew their employee count by -8% last year.

Cancer IQ's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
CTOReveal Email/Phone
3
CFOReveal Email/Phone
4
VP ProductReveal Email/Phone
5
VP Customer SuccessReveal Email/Phone
6
VP SalesReveal Email/Phone
7
SVP, Commercial StrategyReveal Email/Phone
8
Head People and OperationsReveal Email/Phone
9
VP, SalesReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M55-4%N/AN/A
#2
$0.6M8-20%N/AN/A
#3
$5470M110264%$2BN/A
#4
$0.5M16-16%$15MN/A
#5
$1M12-8%N/AN/A
#6
$6.7M534%N/AN/A
#7
$1.3M16-11%N/AN/A
#8
$58.1M332-20%N/AN/A
#9
$3087.2M157516%N/AN/A
#10
$3.7M35-12%$1.4MN/A
Add Company

What Is Cancer IQ?

About Us CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer a genetic evaluation at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease. Why Work with Us? We have quietly built a market-leading product that patients, providers, and healthcare executives all love. With new funding and new strategic partners, we're on pace for rapid growth. We've a team of clever, scrappy, and mission-driven individuals making a huge impact in cancer prevention - so if you're passionate about healthcare - join our team.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$6.8M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cancer IQ News

2022-04-17 - CancerIQ Helps School Administrator Find Her Cancer Early

Ballard consulted with Michele Settelmyer, an advanced practice registered nurse with OSF HealthCare and a CancerIQ champion specializing in...

2022-04-17 - Social Determinants of Health (SDOH) Market to Reflect Steadfast ...

Social Determinants of Health (SDOH) Market to Reflect Steadfast Expansion During 2022-2029 | Arcadia Group, Cancer IQ, Cerner, Color, Optum.

2022-04-17 - IQ-AI subsidiary Imaging Biometrics shares latest progress on Phase I brain cancer study

IQ-AI subsidiary Imaging Biometrics CEO Michael Schmainda shares the latest progress on the group has made on its Phase I brain cancer...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.8M5410%N/A
#2
$7M548%N/A
#3
$10.2M5450%N/A
#4
$5M5423%N/A
#5
$6.8M542%$36.1M